Tidal Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$855K Buy
+39,881
New +$611K ﹤0.01% 1827
2025
Q4
Sell
-36,982
Closed -$553K 2116
2025
Q3
$553K Sell
36,982
-1,043
-3% -$12.7K ﹤0.01% 1520
2025
Q2
$443K Buy
+38,025
New +$345K ﹤0.01% 1483
2024
Q3
Sell
-32,229
Closed -$117K 1825
2024
Q2
$117K Sell
32,229
-5,027
-13% -$16K ﹤0.01% 1738
2024
Q1
$120K Buy
+37,256
New +$144K ﹤0.01% 1604

Other funds holding ADPT

Tidal Investments's ADPT Position: Q2 2026 in Review

Tidal Investments opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 39,881 shares worth $855K. The stake represents ﹤0.01% of the portfolio and ranks #1827 among its holdings. This is a return to the name: Tidal Investments previously reported a position in ADPT as recently as Q3 2025.

Tidal Investments first reported a position in ADPT in Q1 2024 and has held it in 5 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Tidal Investments held 39,881 shares of Adaptive Biotechnologies worth $855K as of Q2 2026.
  • Adaptive Biotechnologies was a new Tidal Investments position in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1827 holding.
  • Tidal Investments first reported a position in Adaptive Biotechnologies in Q1 2024 and has held it in 5 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.